Litigation for acalabrutinib

US Court Litigation for acalabrutinib

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
10,167,291			2022-02-02	2024-07-15	35:271 Patent Infringement	District Court, D. Delaware	None
10,167,291			2022-02-02		35:271 Patent Infringement	District Court, D. Delaware	None
10,167,291	Acerta Pharma B.V. v. Natco Pharma Limited		2022-02-02		35:271 Patent Infringement	District Court, D. Delaware	None
10,167,291	Acerta Pharma B.V. v. Natco Pharma Limited		2022-02-01		35:271 Patent Infringement	District Court, D. Delaware	None
10,167,291			2022-02-04	2024-06-13	35:271 Patent Infringement	District Court, D. Delaware	Defendant
10,167,291			2022-02-03		35:271 Patent Infringement	District Court, D. Delaware	Defendant
10,167,291	Acerta Pharma B.V. v. MSN Pharmaceuticals Inc.		2022-02-04		35:271 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for acalabrutinib

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
10,272,083	Sandoz Inc.		2023-02-03	02-03-2023		Inter partes review		08-07-2023